MedTrace Logo

Developing an In-vitro Diagnostic Risk-Stratification Test for Oral Cancer

NCT01587573 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 370

Last updated 2018-04-12

No results posted yet for this study

Summary

The purpose of this study is to verify the discriminatory value of previously identified salivary transcriptome and proteome markers for oral squamous cell cancer in an intended use population of patients with oral lesions suspicious for cancer.

Conditions

  • Oral Squamous Cell Carcinoma

Interventions

OTHER

saliva collection prior to clinically driven oral biopsy

cell free saliva to be used to measure mRNA and proteins by PCR and ELISA

Sponsors & Collaborators

  • PeriRx

    lead INDUSTRY

Principal Investigators

  • Jack L Martin, MD · PeriRx, LLC

  • Marc Surkin, MD · Main Line Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2018-09-30
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01587573 on ClinicalTrials.gov